Qin Qin

Qin Qin

Auto-generated profile, based on publicly available information

Qin Qin

Department of Cardiology, Tianjin Chest Hospital, Tianjin, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2015 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
NYNing Yang
Ning Yang
QQQin Qin
Qin Qin
Objective: To review the functional mechanism of apolipoprotein J (apoJ) in the process of atherosclerosis and the feasibility of apoJ as a therapeutic endpoint. Data Sources: Relevant articles published in English from 1983 to present were selected from PubMed. The terms of "atherosclerosis, apolipoprotein J, clusterin (CLU), oxidative stress, and inflammation" were used for searching. Study Selection: Articles studying the role of apoJ with atherosclerosis and restenosis after injury were reviewed. Articles focusing on the intrinsic determinants of atherosclerosis were selected. The exclusion criteria of articles were that the studies on immunologic vasculitis. Results: ApoJ, involved in numerous physiological process important for lipid transportation and vascular smooth muscle cell differentiation, including apoptotic cell death, cell-cycle regulation, cell adhesion, tissue remodeling, immune system regulation, and oxidative stress, plays a role in the development of clinical atherosclerosis. In the process of relieving atherosclerosis, apoJ can promote cholesterol and phospholipid export from macrophage-foam cells, and exhibit cytoprotective and anti-inflammatory actions by interacting with lots of known inflammatory proteins which may predict the onset of clinical cardiovascular events and may actually play a causal role in mediating atherosclerotic disease such as C-reactive protein, paraoxonase, and leptin. As known as CLU, apoJ has been identified to play central roles in the process of vascular smooth cells migration, adhesion, and proliferation, which can contribute significantly to restenosis after vascular injury. Conclusions: Intense effort and substantial progress have been made to identify the apoJ that relieves atherosclerosis and vascular restenosis after percutaneous coronary intervention. More work is needed to elucidate the exact mechanisms of and the interrelationship between the actions of apoJ and to successfully achieve regression of atherosclerosis by regarding it as a therapeutic endpoint.

18 October 2013 in Modern Rheumatology
Verified
Journal Article
Closed access
QQQin Qin
Qin Qin
HWHui Wang
Hui Wang
HWHuai-Zhou Wang
Huai-Zhou Wang
YHYuan-Lan Huang
Yuan-Lan Huang
HLHu Li
Hu Li
ADAn-Mei Deng
An-Mei Deng
Objectives. To estimate the diagnostic accuracy of anti-alpha-fodrin antibodies for primary Sjögren's syndrome (pSS). Methods. Sixty-four pSS subjects and 108 non-pSS patients were prospectively enrolled in this study. Serum anti-alpha-fodrin IgA and IgG were detected by ELISA in a blind fashion. The diagnostic accuracy of anti-alpha-fodrin antibodies was assessed by receiver operating characteristic (ROC) curve analysis. Logistic regression was used to investigate whether anti-alpha-fodrin antibodies could improve the accuracy of pSS diagnosis if used in addition to anti-SSA and anti-SSB. Results. The areas under the ROC curves for anti-alpha-fodrin IgG and IgA were 0.69 (95% confidence interval (CI): 0.60–0.77) and 0.63 (95% CI: 0.54–0.72), respectively (P < 0.01 for both). The optimal diagnostic thresholds for anti-fodrin IgG and IgA were 11.75 U/ml and 9.75 U/ml, respectively, with a sensitivity of 0.59 and 0.55, and a specificity of 0.75 and 0.73, respectively. Anti-alpha-fodrin IgG and IgA antibodies were associated with pSS after adjustment for anti-SSA and anti-SSB. Conclusions. Anti-alpha-fodrin IgG and IgA antibodies are useful diagnostic markers which may improve the accuracy of pSS diagnosis.

6 July 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PZPeng Zhang
Peng Zhang
XZXue Zhang
Xue Zhang
JZJay Zhang
Jay Zhang
YSYanqiu Song
Yanqiu Song
TLTing Liu
Ting Liu
ZGZhigang Guo
Zhigang Guo
The aim of this study was to test the preventive effects of nano liposomes against contrast-induced nephropathy (CIN) in New Zealand rabbits. Sixty New Zealand rabbits were randomly divided into four groups, with 15 rabbits in each group: control group, contrast group, hydration group and nano liposome group. Serum creatinine (Scr) and Blood Urea Nitrogen (BUN) were measured before and after injection of the contrast agent iopromide. Oxidative stress markers, such as superoxide dismutase (SOD) and malondialdehyde (MDA), and apoptosis markers, such as Bcl2-Associated X (Bax) and B-cell lymphoma-2 (Bcl-2), were measured by enzyme-linked immunosorbent assay (ELISA). Rabbits were killed 24 h after injection of the contrast medium and both kidneys were removed. Real-time Polymerase Chain Reaction (RT-PCR) and Western blot assays were performed in kidney tissue. Pathological changes were analyzed under the optical and electron microscope. Compared with the hydration group, the nano liposome group showed improved protection of renal function, with significantly different Scr and BUN levels, incidence of CIN, apoptosis index, RT-PCR and Western blot protein expression patterns. Under the optical and electron microscope, the renal injury in the nano liposome group was less than in the hydration group. However, based on SOD and MDA, there was no significant difference in oxidative stress when compared with the hydration group. Apoptosis is an important mechanism in CIN. Nano liposomes can prevent the occurrence of CIN by decreasing apoptosis, reducing damage to the kidney by the contrast agent.

4 September 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
YLYaru Lu
Yaru Lu
HLHui Liu
Hui Liu
BDBo Dong
Bo Dong
JYJingyu Yang
Jingyu Yang
LKLu Kou
Lu Kou
QQQin Qin
Qin Qin
Object: The aim of the present work was to investigate the correlation of plasma platelet‐derived growth factor (PDGF)‐BB level and single nucleotide polymorphism (SNP, rs1800817 and rs2285094) of PDGF‐B gene with the onset and stability condition of coronary heart disease (CHD). Methods: Totally, 335 subjects were included in and divided into CHD ( n = 247) and control group ( n = 88) according to coronary angiography. Besides, the patients in the CHD group were divided into acute coronary syndrome (ACS) group ( n = 165) and stable angina pectoria (SAP) group ( n = 82), based on CHD stability condition. The plasma PDGF‐BB level was measured by ELISA, and the genotype of PDGF‐B was examined through qPCR assay. Results: The PDGF‐BB level was positively correlated with hsCRP level ( r = 0.149, p < 0.05). The genotype frequencies of SNP rs1800817 and rs2285094 match Hardy–Weinberg equilibrium. There was weak linkage disequilibrium between SNP rs1800817 and rs2285094: D′ = 0.419, r 2 = 0.04, which has no correlation with CHD. There was no statistical difference in plasma PDGF‐BB level among different genotypes in rs1800817 and rs2285094. There were no differences in the plasma PDGF‐BB level among patients with any genotype of SNP rs1800817 and rs2285094, no matter how it was grouped. Logistic regression results indicated that the plasma PDGF‐BB level was the independent risk factor of CHD onset (OR = 1.003, 95% CI 1.001–1.006, p = 0.014). Conclusions: High plasma PDGF‐BB level is the risk factor of CHD and has correlation with instability of CHD. The plasma PDGF‐BB level change may be related to inflammatory response. PDGF‐B gene rs1800817 and rs2285094 polymorphisms are not correlated with CHD.

26 June 2018 in Angiology
Verified
Journal Article
Closed access
EZEnyuan Zhang
Enyuan Zhang
YLYaru Lu
Yaru Lu
GCGang Chen
Gang Chen
LHLingyu Huang
Lingyu Huang
JZJingkun Zhang
Jingkun Zhang
QQQin Qin
Qin Qin
Background: Low serum albumin, high blood urea nitrogen (BUN), and uric acid are regarded closely related to the incidence of contrast-induced nephropathy (CIN), whereas it remains unclear whether they can function as predictors of CIN onset. The objective of this systematic review and meta-analysis was to explore the association between abovementioned indicators and CIN incidence rate in patients receiving coronary angiography (CAG) and/or intervention. Methods: Clinical studies were retrieved from the electronic databases of PubMed, EMBASE, Google Scholar, Clinical Trials, and ScienceDirect from their inception to July 13, 2018. Meta-analysis was performed on pooled eligible studies to determine whether these hepatorenal indicators were associated with CIN. Results: A total of 18 studies involving 16 171 patients were included in the meta-analysis. Pooled analysis results revealed that patients with hypoalbuminemia (odds ratio [OR] = 3.09, 95% confidence interval [CI] = 1.44-6.64, P = .004) and hyperuricemia (OR = 1.32, 95% CI = 1.15-1.50, P < .0001) both exhibited significantly higher CIN rates, regardless of the study design, renal function, and whether urgent clinical situation or not. However, there was no significant association between serum BUN and CIN risk. Conclusion: Hypoalbuminemia and hyperuricemia are independently associated with the occurrence of CIN among the patients undergoing CAG and/or intervention.

13 January 2021 in Journal of Bio-X Research
Verified
Journal Article
Open access
CHChengwen He
Chengwen He
WQWei Qin
Wei Qin
JZJun Zhu
Jun Zhu
QQQin Qin
Qin Qin
HWHuaizhou Wang
Huaizhou Wang
SLShanrong Liu
Shanrong Liu
Objective: To identify potential early diagnostic markers for hepatitis B progression to primary liver carcinoma using routine immunological tests based on 6 cytokine combinations. Methods: Eight hundred and ninety-nine patients with hepatitis B progressing to early primary liver carcinoma admitted to and treated at Changhai Hospital, Naval Military Medical University, Shanghai, China between March 2015 and June 2017 were included in this observational study, including 666 patients with HBsAg + , HBeAb + , HBcAb + liver carcinoma and 233 patients with HBsAg + , HBeAg + , HBcAb + liver carcinoma. Receiver operating characteristic (ROC) curves were used to evaluate the efficiency of the different cytokine in the diagnosis of hepatocellular carcinoma in patients with hepatitis B. This study was approved by the Institutional Review Board of Changhai Hospital, Naval Military Medical University, China (approval No. CHEC2020-080) on June 6, 2020. Results: Changed levels of interleukin (IL)-1β, IL-2R, IL-8, and tumor necrosis factor (TNF)-α were statistically significant ( P < 0.05). The area under the ROC curve, sensitivity, specificity, positive predictive value, negative predictive value, and Youden index for the diagnosis of primary liver carcinoma using the combination of IL-1β, IL-2R, IL-8, and TNF-α were 0.938, 79.2%, 96.7%, 96%, 82.0%, 0.759, respectively. The serum alpha-fetoprotein level in patients with primary liver carcinoma was positively correlated with IL-2R ( r =0.3502, P < 0.001), IL-8 ( r =0.1558, P =0.0273), and TNF-α ( r =0.2544, P < 0.001) levels. The equation fitted to the results was logit( P )=0.086+ 0.01 × IL-2R-0.001 × IL-8-0.033 × TNF-α-0.041 × IL-1β. Conclusion: Our study establishes a novel, potentially valuable diagnostic model based on four cytokines related to the early stages of liver carcinoma.